Line chart: Hims & Hers Cash and Cash Equivalents for Hims & Hers Health. Q3 2021-Q2 2026, values in usd_millions. Cash and cash equivalents: 64.8 in Q3 2021 to 609.8 in Q2 2026, peaking at 1,124.6 in Q2 2025.
Cash and cash equivalents
Hims & Hers Monthly Revenue per Average Subscriber
Line chart: Hims & Hers Monthly Revenue per Average Subscriber for Hims & Hers Health. Q4 2024-Q2 2026, values in usd. Monthly revenue per average subscriber: 75 in Q4 2024 to 92 in Q2 2026.
Monthly revenue per average subscriber
Hims & Hers End-of-Period Subscribers
Line chart: Hims & Hers End-of-Period Subscribers for Hims & Hers Health. Q4 2021-Q2 2026, values in thousands. Subscribers (end of period): 554 in Q4 2021 to 2,891 in Q2 2026.
Subscribers (end of period)
Employee Count
Line chart: Employee Count for Hims & Hers Health. 2019-2025. Employees: 4 in 2019 to 2,442 in 2025.
Employees
Hims & Hers Revenue Mix: GLP-1 vs Other Specialties (Quarterly)
Bar chart: Hims & Hers Revenue Mix: GLP-1 vs Other Specialties (Quarterly) for Hims & Hers Health. Q1 2024-Q3 2025, values in USD millions. In Q3 2025: GLP-1 / weight loss 210, Sexual health 200, Dermatology + hair loss 95, Mental health 60, Other specialties 35.
Hims & Hers Quarterly GLP-1 Subscribers: Compounded vs Branded
Bar chart: Hims & Hers Quarterly GLP-1 Subscribers: Compounded vs Branded for Hims & Hers Health. Q2 2024-Q3 2025, values in subscribers. In Q3 2025: Compounded semaglutide / liraglutide 180,000, Branded (Wegovy via NVO partnership) 180,000.
Hims & Hers United States vs Rest of World Revenue
Bar chart: Hims & Hers United States vs Rest of World Revenue for Hims & Hers Health. Q2 2025-Q2 2026, values in usd_millions. In Q2 2026: United States 621.8, Rest of World 131.4.